L-365260 is a selective cholecystokinin receptor 2 (CCK2) antagonist (IC50 are 2 and 280 nM at CCK2 and CCK1 receptors respectively). References: Matto V, Harro J, Allikmets L. The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat. J Physiol Pharmacol. 1996 Dec;47(4):661-9. PubMed PMID: 9116333.

纯度：≥98%

CAS：118101-09-0